ACG Wealth Buys 295 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ACG Wealth increased its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 23.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,569 shares of the healthcare conglomerate’s stock after purchasing an additional 295 shares during the period. ACG Wealth’s holdings in UnitedHealth Group were worth $806,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 1.4% in the first quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock worth $41,119,347,000 after buying an additional 1,147,051 shares in the last quarter. State Street Corp boosted its stake in UnitedHealth Group by 1.6% in the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock worth $23,598,745,000 after buying an additional 714,903 shares in the last quarter. Capital World Investors boosted its stake in UnitedHealth Group by 2.8% in the first quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock worth $17,750,351,000 after buying an additional 935,552 shares in the last quarter. Capital International Investors boosted its stake in UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after buying an additional 790,219 shares in the last quarter. Finally, Capital Research Global Investors boosted its stake in UnitedHealth Group by 8.3% in the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock worth $9,829,129,000 after buying an additional 1,482,338 shares in the last quarter. 87.25% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In related news, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the transaction, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold 139,051 shares of company stock valued at $74,450,958 over the last ninety days. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The business has a fifty day moving average price of $530.11 and a 200-day moving average price of $512.45. The company has a market capitalization of $484.02 billion, a PE ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same period last year, the company earned $4.70 earnings per share. The company’s revenue was up 12.6% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on UNH shares. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Mizuho increased their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Loop Capital assumed coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective for the company. BMO Capital Markets raised their price target on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Finally, Sanford C. Bernstein lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.